Medivation (MDVN) Gains on Sanofi Talks

Medivation Inc (NASDAQ: MDVN) shares picked up 0.7% to $62.20, following a report that it was in talks with Sanofi SA over a sweetened offer. Meidvation later confirmed it had received and rejected an offer of $58.00 per share in cash from Sanfoi, plus a CVR for Talazoparib sales, worth up to $3.00 per share. Share volume was 2.2 million, compared to an all-day average of 3.2 million